Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments

Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

Peter Lackner email, Andrea Part email, Christoph Burger email, Anelia Dietmann email, Gregor Broessner email, Raimund Helbok email, Markus Reindl email, Erich Schmutzhard email and Ronny Beer email

Malaria Journal 2009, 8:36doi:10.1186/1475-2875-8-36

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.